A prognostic factor (PF) index for overall survival in a HER2-negative endocrine-resistant metastatic breast cancer (MBC) population: Analysis from the ATHENA trial.
暂无分享，去创建一个
X. Pivot | J. Pierga | I. Smith | C. Thomssen | K. Pritchard | A. Llombart-Cussac | L. Biganzoli | J. Cortés | H. Cortés-Funes | S. Srock | G. Palacios | M. Sampayo